Trial Information
Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA
Inclusion Criteria:
- Confirmed NSCLC diagnosis (e.g. bronchoscope or FNAB), all stages, men and women,
attending the responsible department of treating this type of patients for the first
time between April 1st 2011 and March 31 2012, for PRO sub-sample: ability to read
and write since they will be asked to participate in the PRO part of the study.
Selection will not be based on the disease stage of each patient, in order to avoid a
selection bias
Exclusion Criteria:
- According to the study design there will not be any exclusion criteria in order to
provide a high validity and to obtain the most accurate real daily practice
information.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Dr. Abdul Rahman Jazieh
Investigator Role:
Study Chair
Investigator Affiliation:
King Fahad National Guard Hospital
Authority:
Saudi Arabia: Ethics Committee
Study ID:
NIS-MENA-SA-IRS-2010/01
NCT ID:
NCT01330862
Start Date:
April 2011
Completion Date:
March 2013
Related Keywords:
- NSCLC Patient Characteristics
- patient outcomes
- Carcinoma, Non-Small-Cell Lung